CRC	colorectal cancer
ICIs	immune checkpoint inhibitors
dMMR	deficient mismatch repair
MSI-H	high microsatellite instability
pMMR	proficient mismatch repair
MSS	microsatellite stability
TME	tumor microenvironment
MLH1	mutL homolog 1
MSH2	mutS homolog 2
MSH6	mutS homolog 6
PMS2	postmeiotic segregation increased 2
mCRC	metastatic CRC
CTLA-4	cytotoxic T lymphocyte-associated antigen-4
TAM	tumor-associated macrophages
DC	dendritic cells
NK	natural killer
TILs	tumor-infiltrating lymphocytes
CTLs	cytotoxic T cells
Tregs	regulatory T cells
HLA-G	human leucocyte antigen-G
SPP1	secreted phosphoprotein 1
CAFs	cancer-associated fibroblasts
MSCs	mesenchymal stem cells
ILCs	innate lymphoid cells
MHC-I	major histocompatibility complex class I
ORR	objective response rate
DCR	disease control rate
OS	overall survival
VEGF	vascular endothelial growth factor
TKIs	tyrosine kinase inhibitors
RCT	randomized controlled trials
PFS	progression-free survival
CAR-T	chimeric antigen receptor T